Use of Aspirin and Clopidogrel After Coronary Artery Bypass Graft Surgery;L'association de l'aspirine et du clopidogrel chez des patients atteints d'un syndrome coronaire aigu revascularisés par pontage aorto-coronarien

Annals of Pharmacotherapy

Volumn 46, Issue 5, 2012, Pages 678-687

  de Leon, Noelle ^a   Jackevicius, Cynthia A ^a,b,c,d  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c TORONTO GENERAL HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Coronary artery bypass graft surgery; Dual antiplatelet therapy

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

BLEEDING; CORONARY ARTERY BYPASS SURGERY; FEASIBILITY STUDY; GASTROINTESTINAL HEMORRHAGE; GRAFT PATENCY; HUMAN; LOADING DRUG DOSE; MORTALITY; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; OBSERVATIONAL STUDY; OFF PUMP CORONARY SURGERY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; SYSTEMATIC REVIEW;

ASPIRIN; CLINICAL TRIALS AS TOPIC; CORONARY ARTERY BYPASS; DRUG THERAPY, COMBINATION; HUMANS; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 84860995253     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1Q692     Document Type: Review

References (38)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics 2011 update: a report from the American Heart Association. Circulation 2011;123:e18-209.
2. Eagle KA, Guyton RA, Davidoff R, et al. ACC/AHA 2004 guideline update for coronary artery bypass surgery. Circulation 2004;110:e340-e437.
3. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation 1998;97:916-931.
4. Cameron AA, Davis KB, Rogers WJ. Recurrence of angina after coronary artery bypass surgery: predictors and prognosis (CASS registry). J Am Coll Cardiol 1995;26:895-899.
5. Goldman S, Copeland J, Moritz T, et al. Long-term graft patency (3 years) after coronary artery surgery: effects of aspirin: results of the VA Cooperative Study. Circulation 1994;89:1138- 1143.
6. Yusuf S, Fox KA, Tognoni G, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
7. Steinhbl SR, Berger PB, Mann JT, et al. Early and sustained dual oral an-tiplatelet therapy following percutaneous coronary intervention. JAMA 2002;288:2411-2420.
8. Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011;124:e652-e735.
9. Kestin AS, Valeri CR, Khuri SF, et al. The platelet function defect of car-diopulmonary bypass. Blood 1993;82:107-117.
10. Verrier ED, Boyle EM. Endothelial cell injury in cardiovascular surgery. Ann Thorac Surg 1996;62:915-922.
11. Gurbel PA, Tantry US. Combination antithrombotic therapies. Circulation 2010;121:569-583.
12. Patrono C, Baigent C, Hirsch J, et al. Antiplatelet drugs: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008;133:1998-2338.
13. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-II: maintenance of vascular graft or arterial patency by antiplatelet therapy. BMJ 1994;308:159-168.
14. Mangano DT, Saidman L, Levin J, et al. Aspirin and mortality from coronary bypass surgery. N Engl J Med 2002;347:1309-1317.
15. Fox KA, Mehta SR, Peters R, et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the clopidogrel in unstable angina to prevent recurrent ischemic events (CURE) trial. Circulation 2004;110:1202-1208.
16. Sorensen R, Abildstrom SZ, Hansen PR, et al. Efficacy of post-operative clopidogrel treatment in patients revascularized with coronary artery bypass grafting after myocardial infarction. J Am Coll Cardiol 2011;57:1202-1209.
17. Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706-1717.
18. Saw J, Topol E, Steinhubl SR, et al. Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention. Am J Cardiol 2004;94:623-625.
19. Gundry SR, Romano MA, Shattuck OH, et al. Seven-year follow-up of coronary artery bypasses performed with and without cardiopulmonary bypass. J Thorac Cardiovasc Surg 1998;115:1273-1278.
20. Bouchard D, Cartier R. Off-pump revascularization of multivessel coronary artery disease has a decreased myocardial infarction rate. Eur J Car-diothorac Surg 1998;14(suppl I):S20-S24.
21. Nielsen AB, Bochsen L, Steinbruchel DA. Hypercoagulability and platelet inhibition after OPCAB: randomized trial with clopidogrel. Scand Cardiovasc J 2007;41:325-330.
22. Kim KB, Lim C, Lee C, et al. Off-pump coronary artery bypass may decrease the patency of saphenous vein grafts. Ann Thorac Surg 2001;72: S1033-S1037.
23. Ibrahim K, Tjomsland O, Halvorsen D, et al. Effect of clopidogrel on midterm graft patency following off-pump coronary revascularization surgery. The Heart Surgery Forum 2006;9(6):e851-e856.
24. Halkos ME, Cooper WA, Petersen R, et al. Early administration of clopi-dogrel is safe after off-pump coronary artery bypass surgery. Ann Thorac Surg 2006;81:815-819.
25. Shennib H, Endo M, Benhameid O. A feasibility study of the safety and efficacy of a combined clopidogrel and aspirin regimen following off-pump coronary artery bypass grafting. The Heart Surgery Forum 2003; 6(5):288-291.
26. Gurbuz AT, Zia AA, Vuran AC, et al. Postoperative clopidogrel improves mid-term outcome after off-pump coronary artery bypass graft surgery: a prospective study. Eur J Cardiothoracic Surg 2006;29:190-195.
27. Chan V, Kulik A, Bourke ME, et al. Clopidogrel is safe early after on-and off-pump coronary artery bypass surgery. J Card Surg 2007;22:493-497.
28. Gao C, Ren C, Li D, et al. Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting. Ann Thorac Surg 2009;88:59-62.
29. Gao G, Zheng Z, Pi Y, et al. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery: a single-center, randomized, controlled trial. J Am Coll Cardiol 2010;56:1639- 1643.
30. Sun JC, Teoh KH, Lamy A, et al. Randomized trial of aspirin and clopi-dogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the preoperative aspirin and postoperative antiplatelets in coronary artery bypass grafting study. Am Heart J 2010;160:1178-1184.
31. Kulik A, Le MR, Voisine P, et al. Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) trial. Circulation 2010;122:2680 -2687.
32. Brook Army Medical Center. Aspirin and Plavix following coronary artery bypass grafting (ASAP-CABG). In: ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine (US). 2000. http://clinicaltrials.gov/ct2/show/NCT01158703?term=asap-cabg&rank=1NLMIdentifierNCT01158703 (accessed 2011 Nov 30).
33. Rigshospitalet, Denmark. ThromboElastoGraphic coagulation status and antiplatelet therapy after coronary artery bypass graft surgery (TEG-CABG). In: ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine (US). 2000. http://clinicaltrials.gov/ct2/show/NCT01046942?term=TEG+CABG&rank=1NLMIdentifierNCT01046942 (accessed 2011 Nov 30).
34. Kim DH, Daskalakis C, Silvestry SC, et al. Aspirin and clopidogrel use in the early postoperative period following on-pump and off-pump coronary artery bypass grafting. J Thorac Cardiovasc Surg 2009;138:1377-1384.
35. Sanon S, Lee VV, Elayda M, et al. Use of aspirin versus clopidogrel plus aspirin after coronary artery bypass graft surgery. Clinical and Applied Thrombosis/Hemostasis 2009;15:540- 544.
36. University of Zagreb. Dual antiplatelet therapy in patients with aspirin resistance following coronary artery bypass grafting. In: ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine (US). 2000. http://clinicaltrials.gov/ct2/show/NCT01159639?term=antiplatelet+ther-apy+in+aspirin+resistance&rank=1NLMIdentifierNCT01159639 (accessed 2011 Nov 30).
37. Becker RC, Meade TW, Berger PB, et al. The primary and secondary prevention of coronary artery disease: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 2008;133:776S-814S.
38. Stein PD, Schunemann HJ, Dolen JE, et al. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126:600S-608S.